Answers are grounded in this paper and cite their sources.
Retrospective analysis highlights progression of structural lung disease in Aspergillus phenotypes, indicating different risks for allergic bronchopulmonary aspergillosis.
Aspergillus fumigatus (Asp) is frequently cultured from airways of children with Cystic Fibrosis (CwCF), but the impact on structural lung disease (SLD) remains unknown. In this retrospective study of 125 CwCF with a positive Asp airway culture (Asp+) at Sophia Children’s Hospital between 1988 and 2021, four Asp disease phenotypes were defined based on serum Asp-specific IgE (IgEAsp) and IgG (IgGAsp): colonisation, sensitisation, bronchitis, and allergic bronchitis. SLD was assessed on biennial chest CTs (n = 382) using the PRAGMA-CF score. Annual progression of SLD was modelled for the Asp disease phenotypes, adjusting for Pseudomonas aeruginosa and Allergic Bronchopulmonary Aspergillosis (ABPA). Annual SLD progression was high in all phenotypes but was higher in Asp sensitisation and bronchitis compared to colonisation. The proportion of air trapping was high in the full study population (mean 57%), but no differences were found in annual progression between the different Asp disease phenotypes. CwCF with Asp allergic bronchitis had a 10-fold higher risk to develop ABPA during the study follow-up than those with Asp colonisation. The four Asp disease phenotypes, colonisation, sensitisation, bronchitis, and allergic bronchitis, that were defined based on IgEAsp and IgGAsp show different rates of progression of SLD and different risks of ABPA development.
No takes yet. Share an insight, caveat, or question.
Mollica et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: